Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1967 2
1968 2
1969 3
1970 2
1972 3
1973 3
1975 5
1977 7
1978 4
1979 6
1980 2
1981 5
1982 5
1983 8
1984 9
1985 6
1986 17
1987 11
1988 13
1989 21
1990 15
1991 19
1992 16
1993 21
1994 18
1995 17
1996 23
1997 20
1998 31
1999 31
2000 21
2001 24
2002 44
2003 30
2004 31
2005 46
2006 82
2007 72
2008 67
2009 62
2010 51
2011 75
2012 66
2013 74
2014 96
2015 98
2016 107
2017 94
2018 82
2019 89
2020 89
2021 116
2022 98
2023 92
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

1,856 results

Results by year

Filters applied: . Clear all
Page 1
Essential thrombocythemia: challenges in clinical practice and future prospects.
Godfrey AL, Green AC, Harrison CN. Godfrey AL, et al. Blood. 2023 Apr 20;141(16):1943-1953. doi: 10.1182/blood.2022017625. Blood. 2023. PMID: 36379024 Free article. Review.
Essential thrombocythemia (ET) was first described in 1934, and subsequently, progress has been made in better understanding the molecular pathogenesis and which patients may have greatest risk of progression or vascular events. ...
Essential thrombocythemia (ET) was first described in 1934, and subsequently, progress has been made in better understanding t …
Essential Thrombocythemia.
Tefferi A, Pardanani A. Tefferi A, et al. N Engl J Med. 2019 Nov 28;381(22):2135-2144. doi: 10.1056/NEJMcp1816082. N Engl J Med. 2019. PMID: 31774958 Review. No abstract available.
Current management strategies for polycythemia vera and essential thrombocythemia.
Guglielmelli P, Vannucchi AM. Guglielmelli P, et al. Blood Rev. 2020 Jul;42:100714. doi: 10.1016/j.blre.2020.100714. Epub 2020 Jun 3. Blood Rev. 2020. PMID: 32546373 Review.
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms characterized by increased rate of cardiovascular events, a varying burden of symptoms, and an intrinsic risk of evolution to secondary forms of myelofibrosis and acute leukem …
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms characterized by increased rate of …
Pediatric Myeloproliferative Neoplasms.
El-Sharkawy F, Margolskee E. El-Sharkawy F, et al. Clin Lab Med. 2021 Sep;41(3):529-540. doi: 10.1016/j.cll.2021.04.010. Clin Lab Med. 2021. PMID: 34304780 Review.
Very few studies have focused on the diagnosis, prognosis, and therapy for pediatric myeloproliferative neoplasms. This article focuses on chronic myeloid leukemia, essential thrombocythemia, polycythemia vera, and primary myelofibrosis in children....
Very few studies have focused on the diagnosis, prognosis, and therapy for pediatric myeloproliferative neoplasms. This article focuses on c …
Myeloproliferative Disorders.
Meier B, Burton JH. Meier B, et al. Hematol Oncol Clin North Am. 2017 Dec;31(6):1029-1044. doi: 10.1016/j.hoc.2017.08.007. Hematol Oncol Clin North Am. 2017. PMID: 29078922 Review.
Myeloproliferative disorders.
Meier B, Burton JH. Meier B, et al. Emerg Med Clin North Am. 2014 Aug;32(3):597-612. doi: 10.1016/j.emc.2014.04.014. Epub 2014 Jun 7. Emerg Med Clin North Am. 2014. PMID: 25060252 Review.
A review of essential thrombocythemia and its complications.
Babakhanlou R, Masarova L, Verstovsek S. Babakhanlou R, et al. Clin Adv Hematol Oncol. 2023 Feb;21(2):76-84. Clin Adv Hematol Oncol. 2023. PMID: 36780473 Review.
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by an increased platelet count in the peripheral blood and excessive megakaryopoiesis in the bone marrow. ...
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by an increased platelet count in the pe …
Developments in diagnosis and treatment of essential thrombocythemia.
Mora B, Passamonti F. Mora B, et al. Expert Rev Hematol. 2019 Mar;12(3):159-171. doi: 10.1080/17474086.2019.1585239. Epub 2019 Mar 13. Expert Rev Hematol. 2019. PMID: 30793984 Review.
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by thrombocytosis, increased risk of thrombotic/hemorrhagic events and clonal evolution into blast phase or myelofibrosis. ...
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by thrombocytosis, increased risk of thr …
Essential thrombocythemia.
Harrison CN, Green AR. Harrison CN, et al. Hematol Oncol Clin North Am. 2003 Oct;17(5):1175-90, vii. doi: 10.1016/s0889-8588(03)00082-0. Hematol Oncol Clin North Am. 2003. PMID: 14560781 Review.
Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet no pathognomonic diagnostic test, and patients who currently fall into the category of essential thrombocythemia are likely to …
Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet n …
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs.
Iurlo A, Bucelli C, Cattaneo D. Iurlo A, et al. Curr Treat Options Oncol. 2023 Jul;24(7):802-820. doi: 10.1007/s11864-023-01099-8. Epub 2023 May 17. Curr Treat Options Oncol. 2023. PMID: 37195587 Review.
Current treatment of essential thrombocythemia (ET) should primarily prevent thrombo-hemorrhagic events, without increasing the rate of fibrotic progression or leukemic evolution, and secondarily control microvascular symptoms. ...
Current treatment of essential thrombocythemia (ET) should primarily prevent thrombo-hemorrhagic events, without increasing th …
1,856 results